Steven Cohen’s Rhythm Pharmaceuticals RYTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$69.2M Buy
726,499
+312,289
+75% +$33.3M 0.08% 316
2026
Q2
$46M Sell
414,210
-432,591
-51% -$39.1M 0.05% 468
2026
Q1
$73.6M Buy
846,801
+417,381
+97% +$40.6M 0.09% 242
2025
Q4
$46M Buy
+429,420
New +$45.6M 0.05% 444
2025
Q3
– Sell
-170,832
Closed -$10.8M – 2633
2025
Q2
$10.8M Buy
170,832
+106,990
+168% +$6.55M 0.02% 705
2025
Q1
$3.38M Buy
+63,842
New +$3.54M 0.01% 1081
2023
Q4
– Sell
-4,146
Closed -$95K – 2729
2023
Q3
$95K Buy
+4,146
New +$92.8K ﹤0.01% 1978
2023
Q2
– Sell
-11,955
Closed -$213K – 2706
2023
Q1
$213K Buy
+11,955
New +$300K ﹤0.01% 1464
2018
Q2
– Sell
-180,000
Closed -$3.58M – 1155
2018
Q1
$3.58M Buy
180,000
+100,000
+125% +$2.66M 0.02% 644
2017
Q4
$2.32M Buy
+80,000
New +$2.12M 0.01% 711

Other funds holding RYTM

Steven Cohen's RYTM Position: Q3 2026 in Review

Steven Cohen increased its Rhythm Pharmaceuticals (RYTM) stake by 75% in Q3 2026, buying an estimated $33.3M and bringing the position to 726,499 shares worth $69.2M. The position accounts for 0.08% of the portfolio, ranked #316.

Steven Cohen first reported a position in RYTM in Q4 2017 and has held it in 10 quarters since. The position peaked at $73.6M in Q1 2026. 329 funds tracked by Wall St. Rank hold RYTM as of Q3 2026.

  • Steven Cohen held 726,499 shares of Rhythm Pharmaceuticals worth $69.2M as of Q3 2026.
  • Steven Cohen bought 312,289 Rhythm Pharmaceuticals shares in Q3 2026, an estimated $33.3M.
  • Rhythm Pharmaceuticals made up 0.08% of Steven Cohen's portfolio in Q3 2026, its #316 holding.
  • Steven Cohen first reported a position in Rhythm Pharmaceuticals in Q4 2017 and has held it in 10 quarters since.
  • Steven Cohen's Rhythm Pharmaceuticals position peaked at $73.6M in Q1 2026.
  • 329 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.